HQL   $13.82  -0.07% Market Closed

Tekla Life Sciences Investors
Total Cash
totalCashPerShare
EBITDA
Total Debt 0.00
quickRatio 0.001
currentRatio 0.268
Total Revenue 3.51M
debtToEquity
Revenue/Share 0.134
ROA -0.00318
ROE 0.01281
grossProfits
freeCashflow
operatingCashflow
earningsGrowth 0.42
revenueGrowth 0.07
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -0.31634
profitMargins 1.5645399
enterpriseValue
forwardPE
floatShares
sharesOutstanding 27.35M
sharesShort 62.30K
sharesShortPriorMonth 154.07K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.37%
Short Ratio help_outline 0.74%
shortPercentOfFloat
impliedSharesOutstanding
bookValue 16.126
Price To Book help_outline 0.93
earningsQuarterlyGrowth 0.49
netIncomeToCommon 5.50M
trailingEps 1.34%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 87
lastUpdated Nov. 6, 2024, 3:31 p.m.